The U.S. Food and Drug Administration (FDA) approved a new influenza drug called Rapivab (peramivir).drugs_dees Rapivab is given intravenously as a single dose in adults who have been symptomatic with the flu for no more than two days. This drug is in the neuraminidase family of drugs which includes Tamiflu and Relenza, which are oral medications.

I have written extensively about the failures of the oral flu medications in my blog and in my newsletter, Dr. Brownstein’s Natural Way to Health.

The neuraminidase inhibitors, in the best studies, have been found to lessen the symptoms from the flu for less than 24 hours. This new medication showed the same effect. All the neuraminidase inhibitors are associated with serious side effects including nausea, vomiting and headaches. Wait a second—I thought those symptoms were associated with the flu? Tamiflu has been associated with more serious side effects such as psychiatric events and heart rhythm abnormalities. With side effects like those, perhaps a cup of chicken soup is a better option!